Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Gimistotug, an antibody targeting OX40.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Eltrekibart, an antibody targeting CXCL1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Ebribafusp, an antibody targeting C3d.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Crebankitug, an antibody targeting IL-7R.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Coramitug, an antibody targeting Misfolded TTR.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Cepeprubart, an antibody targeting SELPLG.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Cafelkibart, an antibody targeting CCR8.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Adakitug, an antibody targeting CXCL8.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Abiprubart, an antibody targeting TNFRSF5.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Recibokibart, an antibody targeting IL1RL2.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Potravitug, an antibody targeting BK polyomavirus VP1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Etalanetug, an antibody targeting Tau.